Skip to main content
Bioceltix S.A. logo

Bioceltix S.A. — Investor Relations & Filings

Ticker · BCX ISIN · PLBCLTX00019 LEI · 259400QZD5JYK8SLZU51 WAR Manufacturing
Filings indexed 270 across all filing types
Latest filing 2026-04-29 Capital/Financing Update
Country PL Poland
Listing WAR BCX

About Bioceltix S.A.

https://bioceltix.com/en/

Bioceltix S.A. is a biopharmaceutical company that develops stem cell-based medicinal products for veterinary use. The company focuses on creating therapies that utilize Mesenchymal Stem Cells (MSCs) as the active pharmaceutical ingredient. Its product pipeline is aimed at treating immunological and inflammatory conditions in companion animals, including dogs, cats, and horses. A key area of development includes treatments for conditions such as atopic dermatitis in dogs and degenerative joint disease.

Recent filings

Filing Released Lang Actions
Informacja o pozytywnej ocenie projektu pt.: "Innowacyjny bezkomórkowy lek biologiczny dla zastosowań w weterynarii (InnoBioVet)" w ramach programu Fundusze Europejskie dla Nowoczesnej Gospodarki -...
Capital/Financing Update Classification · 1% confidence The document is a management board announcement informing that the company’s R&D project received a positive evaluation and potential grant funding from a national research agency. It is not a full financial report, earnings release, or a routine regulatory notice; rather it provides an update on an incoming financing (grant funding) that will materially affect the company’s capital resources. This fits the definition of a Capital/Financing Update (CAP).
2026-04-29 Polish
Podpisy do Opinii biegłego rewidenta z badania Sprawozdania Finansowego Bioceltix S.A. za okres 01.01.2025-31.12.2025
Regulatory Filings
2026-04-28 Polish
Opinia biegłego rewidenta z badania Sprawozdania Finansowego Bioceltix S.A. za okres 01.01.2025-31.12.2025
Regulatory Filings
2026-04-28 Polish
Podpisy do Sprawozdania Zarządu z Działalności Bioceltix S.A. za okres sprawozdawczy zakończony 31.12.2025 r.
Regulatory Filings
2026-04-28 Polish
Sprawozdanie Zarządu z Działalności Bioceltix S.A. za okres sprawozdawczy zakończony 31.12.2025 r.
Regulatory Filings
2026-04-28 Polish
Podpisy do Sprawozdania Finansowego Bioceltix S.A. za okres 01.01.2025-31.12.2025
Regulatory Filings
2026-04-28 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.